Garlic intake and cancer risk: an analysis using the Food and Drug Administration’s evidence-based review system for the scientific evaluation of health claims | Zendy

Ji Yeon Kim | Zendy; Oran Kwon | Zendy

Open Access

Garlic intake and cancer risk: an analysis using the Food and Drug Administration’s evidence-based review system for the scientific evaluation of health claims

Author(s) -

Ji Yeon Kim,

Oran Kwon

Publication year - 2008

Publication title -

american journal of clinical nutrition

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.608

H-Index - 336

eISSN - 1938-3207

pISSN - 0002-9165

DOI - 10.3945/ajcn.2008.26142

Subject(s) - food and drug administration , drug , medicine , environmental health , drug administration , health claims on food labels , administration (probate law) , risk analysis (engineering) , food science , pharmacology , biology , political science , law

Numerous animal and in vitro studies provided evidence for a relation between garlic intake and cancer risk reduction. Several studies also reported an inverse association in humans. However, no claims have been made about garlic intake and cancer risk reduction with respect to food labeling.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research